GRT-R910

UK begins trial of multivariant COVID-19 vaccine booster

It will explore the potential of the drug to boost the immune response of first-generation COVID-19 vaccines to a wide array of variants of Sars-Cov-2, which cause COVID-19.

published on : 21st September 2021
edexworks